TY - JOUR
T1 - Rapid Conversion of Fibroblasts into Functional Forebrain GABAergic Interneurons by Direct Genetic Reprogramming
AU - Colasante, Gaia
AU - Lignani, Gabriele
AU - Rubio, Alicia
AU - Medrihan, Lucian
AU - Yekhlef, Latefa
AU - Sessa, Alessandro
AU - Massimino, Luca
AU - Giannelli, Serena G.
AU - Sacchetti, Silvio
AU - Caiazzo, Massimiliano
AU - Leo, Damiana
AU - Alexopoulou, Dimitra
AU - Dell'Anno, Maria Teresa
AU - Ciabatti, Ernesto
AU - Orlando, Marta
AU - Studer, Michele
AU - Dahl, Andreas
AU - Gainetdinov, Raul R.
AU - Taverna, Stefano
AU - Benfenati, Fabio
AU - Broccoli, Vania
PY - 2015/12/3
Y1 - 2015/12/3
N2 - Transplantation of GABAergic interneurons (INs) can provide long-term functional benefits in animal models of epilepsy and other neurological disorders. Whereas GABAergic INs can be differentiated from embryonic stem cells, alternative sources of GABAergic INs may be more tractable for disease modeling and transplantation. We identified five factors (Foxg1, Sox2, Ascl1, Dlx5, and Lhx6) that convert mouse fibroblasts into induced GABAergic INs (iGABA-INs) possessing molecular signatures of telencephalic INs. Factor overexpression activates transcriptional networks required for GABAergic fate specification. iGABA-INs display progressively maturing firing patterns comparable to cortical INs, form functional synapses, and release GABA. Importantly, iGABA-INs survive and mature upon being grafted into mouse hippocampus. Optogenetic stimulation demonstrated functional integration of grafted iGABA-INs into host circuitry, triggering inhibition of host granule neuron activity. These five factors also converted human cells into functional GABAergic INs. These properties suggest that iGABA-INs have potential for disease modeling and cell-based therapeutic approaches to neurological disorders.
AB - Transplantation of GABAergic interneurons (INs) can provide long-term functional benefits in animal models of epilepsy and other neurological disorders. Whereas GABAergic INs can be differentiated from embryonic stem cells, alternative sources of GABAergic INs may be more tractable for disease modeling and transplantation. We identified five factors (Foxg1, Sox2, Ascl1, Dlx5, and Lhx6) that convert mouse fibroblasts into induced GABAergic INs (iGABA-INs) possessing molecular signatures of telencephalic INs. Factor overexpression activates transcriptional networks required for GABAergic fate specification. iGABA-INs display progressively maturing firing patterns comparable to cortical INs, form functional synapses, and release GABA. Importantly, iGABA-INs survive and mature upon being grafted into mouse hippocampus. Optogenetic stimulation demonstrated functional integration of grafted iGABA-INs into host circuitry, triggering inhibition of host granule neuron activity. These five factors also converted human cells into functional GABAergic INs. These properties suggest that iGABA-INs have potential for disease modeling and cell-based therapeutic approaches to neurological disorders.
KW - 4 aminobutyric acid A receptor
KW - 4 aminobutyric acid receptor
KW - glutamate decarboxylase 65
KW - protein bcl 2
KW - protein homer 1
KW - synaptotagmin I
KW - transcription factor
KW - transcription factor DLX5
KW - transcription factor Foxg1
KW - transcription factor Lhx6
KW - transcription factor Mash1
KW - transcription factor Sox2
KW - unclassified drug
KW - vesicular glutamate transporter 1
KW - 4 aminobutyric acid release
KW - article
KW - fibroblast
KW - forebrain
KW - hippocampus
KW - human
KW - immunofluorescence
KW - interneuron
KW - nerve cell network
KW - nonhuman
KW - priority journal
KW - synapse
KW - telencephalon
U2 - 10.1016/j.stem.2015.09.002
DO - 10.1016/j.stem.2015.09.002
M3 - Article
SN - 1934-5909
VL - 17
SP - 719
EP - 734
JO - Cell Stem Cell
JF - Cell Stem Cell
IS - 6
ER -